Search - tctmd.com

Displaying 921 - 940 of 1188

Sort: Relevancy | Date

Presentation TCT 2014

The Data Strongly Support Heparin!

Presenter: Stefanie Schüpke

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Bivalirudin!

Presenter: Roxana Mehran

September 14, 2014

Presentation TCT 2014

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

Presenter: Kishore J. Harjai, Michael S. Lee

September 14, 2014

News Conference News TCT 2014

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

September 14, 2014

Presentation TCT 2014

Antithrombin Therapy and GP IIb/IIIa Inhibitors in Patients with ACS and in Those Undergoing PCI

Presenter: Frederick Feit, Sripal Bangalore

September 13, 2014

Presentation TCT 2014

Are GP IIb/IIIa Inhibitors Still Useful?

Presenter: Marco Valgimigli

September 13, 2014

News Conference News TCT 2014

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

September 13, 2014

News Daily News

STREAM: La Estrategia Inicial Fibrinolítica es Segura al cabo de 1 Año cuando la realización de una PCI Primaria en el Momento Adecuado es Inalcanzable

L.A. McKeown

September 11, 2014

News Conference News ESC 2014

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

Todd Neale

September 02, 2014

News Conference News ESC 2014

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

Yael L. Maxwell

September 01, 2014

Presentation

Bivalirudin vs Heparin in Patients Planned for PCI

Presenter: Matthew A. Cavender

August 20, 2014

News Daily News

心肌梗塞患者院内抗血小板药切换比较常见，主要原因是患者风险及其他因素

L.A. McKeown

August 20, 2014

News Daily News

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

Todd Neale

August 20, 2014

News Daily News

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

L.A. McKeown

August 20, 2014

News Daily News

El Cambio Intrahospitalario de Agentes Antiplaquetarios en Pacientes PCI es Relativamente Frecuente y está Condicionado por el Riesgo del Paciente y Otros Factores

L.A. McKeown

August 20, 2014

Presentation

In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients with AMI Treated with PCI

Presenter: Akshay Bagai

August 12, 2014

News Daily News

Pre-AMI Ischemia May Reduce Early Mortality

July 24, 2014

Presentation

Pharmacotherapy for Primary PCI - Late Breaking Trials: EUROMAX, HEAT-PPCI, BRIGHT, and BRAVE 4

Presenter: Gregg W. Stone

July 23, 2014

News Daily News

Subestudio del Ensayo STREAM: El Fracaso de los Agentes Líticos Equivale a Peores Resultados en Pacientes STEMI sometidos a Terapia Fármacoinvasiva

July 17, 2014

News Daily News

STREAM分项研究：细胞溶解失败将给接受药物介入治疗的STEMI患者带来更差的结果

July 17, 2014

Advertisement

The Data Strongly Support Heparin!

The Data Strongly Support Bivalirudin!

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

Antithrombin Therapy and GP IIb/IIIa Inhibitors in Patients with ACS and in Those Undergoing PCI

Are GP IIb/IIIa Inhibitors Still Useful?

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

STREAM: La Estrategia Inicial Fibrinolítica es Segura al cabo de 1 Año cuando la realización de una PCI Primaria en el Momento Adecuado es Inalcanzable

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

Bivalirudin vs Heparin in Patients Planned for PCI

心肌梗塞患者院内抗血小板药切换比较常见，主要原因是患者风险及其他因素

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

El Cambio Intrahospitalario de Agentes Antiplaquetarios en Pacientes PCI es Relativamente Frecuente y está Condicionado por el Riesgo del Paciente y Otros Factores

In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients with AMI Treated with PCI

Pre-AMI Ischemia May Reduce Early Mortality

Pharmacotherapy for Primary PCI - Late Breaking Trials: EUROMAX, HEAT-PPCI, BRIGHT, and BRAVE 4

Subestudio del Ensayo STREAM: El Fracaso de los Agentes Líticos Equivale a Peores Resultados en Pacientes STEMI sometidos a Terapia Fármacoinvasiva

STREAM分项研究：细胞溶解失败将给接受药物介入治疗的STEMI患者带来更差的结果

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content